Clover Health Investments Q4 EPS $(0.15) Misses $(0.14) Estimate, Sales $510.25M Beat $480.25M Estimate
Portfolio Pulse from Happy Mohamed
Clover Health Investments (NASDAQ:CLOV) reported Q4 earnings with a per-share loss of $(0.15), missing the $(0.14) estimate, but surpassed sales estimates with $510.25M against the expected $480.25M. This represents a decrease in losses and a significant drop in sales compared to the same period last year.
March 12, 2024 | 8:52 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Clover Health's Q4 report shows a slight miss on EPS estimates but a beat on sales forecasts, with a notable decrease in losses and a significant drop in sales YoY.
The mixed results with a miss on EPS but a beat on sales forecasts could lead to a neutral short-term impact on CLOV's stock price. The reduction in losses is positive, but the significant drop in sales year-over-year might raise concerns among investors about the company's growth trajectory.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100